Protective effect of BoNT found for different indications, including in cosmetic use/facial muscles, migraine/facial and head muscles
Small increase in risk for depression or clinically relevant depressive symptoms but no difference in mood scores seen with long-term use
Risk for severe maternal morbidities and maternal mortality higher for pregnant women who have disabilities, regardless of disability type
The Self-Administered Gerocognitive Examination detects the conversion from mild cognitive impairment to dementia sooner than the MMSE
Drug unaffordability is an issue regardless of insurance status and across private, public payers
Review and meta-analysis show increased risk for violence perpetration for men and women with schizophrenia spectrum disorders